Blog
Get the latest blog updates from LabCentral sent directly to your email by subscribing here.
Get the latest blog updates from LabCentral sent directly to your email:
embeThank you for subscribing!
-
Resident Company Q&A: TreeFrog Therapeutics
October 17, 2022 | By Lindsay CrockettDisclaimer: the views, thoughts, and opinions expressed in this blog belong solely to the individual author, and not to LabCentral or the…
-
LabCentral Ignite Honors Local Leaders with First Annual BioDiversity Awards
October 11, 2022 | By Gretchen Cook AndersonAt LabCentral Ignite, we just hosted our inaugural bioDiversity Summit & Awards. The two-day event brought together more than 250 life…
-
Gallery 1832: Fueling Scientific Innovation through Art
September 26, 2022 | By Shazia MirAt LabCentral, we understand the importance of creativity when it comes to making scientific breakthroughs in the life sciences field. In…
-
LabCentral Ignite Hosts First Annual bioDiversity Summit & Awards
September 22, 2022 | By Gretchen Cook AndersonHistorically, the biotech field has overlooked the opportunity to position itself as a sought after employer to a large, more highly…
-
Pride Q&A with Amy Ripka, CEO and Founder at Lucy Therapeutics
June 27, 2022 | By Kelly WilsonFor the month of June, we'll be featuring LGBTQIA+ staff and residents in the LabCentral community. This month features Amy…
-
Pride Q&A with Gerry Deshycka, Research Associate at Cerberus Therapeutics
June 17, 2022 | By Kelly WilsonFor the month of June, we'll be featuring LGBTQIA+ staff and residents in the LabCentral community. This month…
-
PRIDE Q&A WITH NATHAN HIGGINSON-SCOTT, CTO AND SVP OF DRUG CREATION AT SEISMIC THERAPEUTIC!
June 10, 2022 | By Kelly WilsonFor the month of June, we'll be featuring LGBTQIA+ staff and residents in the LabCentral community. This month…
-
LabCentral Ignite Golden Ticket Spotlight: Harmony – A New Take on Baby Formula
June 08, 2022 | By Sara MurjiThe Ignite Golden Ticket program awards companies working on high-impact science focused on solving problems for human health with a founder…
-
Pride Q&A with Paul Yaworksy, CSO at Mediar Therapeutics!
June 03, 2022 | By Kelly WilsonFor the month of June, we'll be featuring LGBTQIA+ staff and residents in the LabCentral community. This month…
-
Resident Company Q&A: Seismic Therapeutic
May 18, 2022 | By Lindsay CrockettAs part of our blog series profiling LabCentral resident and alumni companies, we’re taking a look at Seismic Therapeutic, a biotech…